Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the efficacy of zonisamide (Zonegran; 100mg
- 400mg/day) and placebo as an adjunctive agent on lowering weight in subjects who have a
body mass index (BMI) of >25 and are on a psychotropic medication with a known side effect of
weight gain.
Phase:
Phase 4
Details
Lead Sponsor:
Tuscaloosa Research & Education Advancement Corporation